Broadening indications for neoadjuvant immunotherapy

Br J Dermatol. 2020 Sep;183(3):421-422. doi: 10.1111/bjd.18873. Epub 2020 Feb 3.
No abstract available

Publication types

  • Comment

MeSH terms

  • Humans
  • Immunotherapy
  • Ipilimumab
  • Melanoma* / drug therapy
  • Neoadjuvant Therapy*
  • Nivolumab

Substances

  • Ipilimumab
  • Nivolumab